ArticleBMC psychiatry2025
Prevalence and predictors of non-medical and lifetime use of controlled drugs among patients accessing mental health services at the university of Gondar comprehensive specialized hospital: Northwest Ethiopia.
Article in BMC psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Behavioral and social pathways of adolescent drug use in Indonesia: implications for community-based prevention.BMC public health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundNonmedical prescription drug use (NMPDU) typically refers to the consumption of medications that have not been prescribed to the user or are used in a manner not intended by the prescriber. NMPDU may pose various health risks, including the development of abuse or dependence, particularly in individuals with mental health problems. This issue, however, has not yet been thoroughly assessed in Ethiopia.
objectiveWe determined the prevalence and predictors of controlled prescription drugs, non-medical, and lifetime use among patients accessing mental health services in the University of Gondar Comprehensive Specialized Hospital (UoGCSH).
methodsA hospital-based cross-sectional study was conducted at UoGCSH from June 17, 2022, to July 28, 2022, involving 146 participants. A convenience sampling technique was used to recruit the study participants, and data were collected through face-to-face interviews using a semi-structured questionnaire. The data were analyzed using the Statistical Package for Social Sciences (SPSS) version 25. Descriptive analysis was conducted to examine sociodemographic characteristics and the prevalence of Controlled Prescription Drugs (CPD) use. Multivariate logistic regression was performed to identify predictors, with statistical significance set at P ≤ 0.05.
resultOf the 146 participants, 12 (8.20%): 95% CI (3.63-12.81) reported having used CPD for non-medical purposes at some point in their lifetime. The most commonly used drugs were tramadol capsules and tramadol injections, reported by 11 participants (91.7%), and followed by amitriptyline (8.3%). The odds of CPD use were significantly higher among patients treated in the outpatient setting (AOR = 7.609, 95% CI = 1.429-40.507) compared to those treated as inpatients. Nine (75%) participants reported using CPD for non-medical purposes to relieve post-operative pain, while the remaining participants cited restlessness as the primary reason for their use.
conclusionThe results of this study revealed that tramadol, in both intravenous and oral forms, was the most frequently abused drug. It was found that patients treated in outpatient settings had greater exposure to CPD use. It is crucial to evaluate the impact of nonmedical CPD use on the health of individuals with mental health conditions and prioritize efforts to improve the quality of care for high-risk individuals.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.